OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

USP32-regulated LAMTOR1 ubiquitination impacts mTORC1 activation and autophagy induction
Alexandra Hertel, Ludovico Martins Alves, Henrik Dutz, et al.
Cell Reports (2022) Vol. 41, Iss. 10, pp. 111653-111653
Open Access | Times Cited: 15

Showing 15 citing articles:

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer
Xueqi Ou, Yeru Tan, Jindong Xie, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101063-101063
Open Access | Times Cited: 81

TRAF4‐Mediated LAMTOR1 Ubiquitination Promotes mTORC1 Activation and Inhibits the Inflammation‐Induced Colorectal Cancer Progression
Linlin Zhao, Ni Gao, Xiao-Ping Peng, et al.
Advanced Science (2024) Vol. 11, Iss. 12
Open Access | Times Cited: 9

LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer
Bo Wu, Xin Huang, Xiang Shi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5

Post-translational regulation of the mTORC1 pathway: A switch that regulates metabolism-related gene expression
Yitao Wang, Tobías Engel, Xinchen Teng
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2024) Vol. 1867, Iss. 1, pp. 195005-195005
Closed Access | Times Cited: 4

Reply to: Amino acids and KLHL22 do not activate mTORC1 via DEPDC5 degradation
Jie Chen, Yuhui Ou, Ying Liu
Nature (2025) Vol. 637, Iss. 8045, pp. E15-E17
Closed Access

Huib32: A Potent and Selective USP32 Inhibitor Modulating Endosomal Processes and Advancing Cell-Permeable USP32 Probes
Stephan Scherpe, Vito Pol, Raymond Kooij, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Deubiquitinases as novel therapeutic targets for diseases
Yali Xian, Jing Ye, Yu Tang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 3

Lycobetaine Has Therapeutic Efficacy in Lung Squamous Cell Carcinoma by Targeting USP32 to Trigger Ferroptosis
Shangping Xing, Hua Chai, Zhenlong Chen, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 163-163
Open Access

USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target
Shuang Li, Yang Song, Kexin Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9

An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variant
Hannah Mende, Anshu Khatri, Carolin Lange, et al.
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113484-113484
Open Access | Times Cited: 3

LAMTOR1 ubiquitination restricts its interaction with the vacuolar-type H+-ATPase, promotes autophagy and is controlled by USP32
Alexandra Hertel, Stefan Eimer, Anja Bremm
Autophagy (2023) Vol. 19, Iss. 8, pp. 2406-2407
Open Access | Times Cited: 2

Progress in the study of autophagy-related proteins affecting resistance to chemotherapeutic drugs in leukemia
Meng Li, Jing Li, Shiming Zhang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access

Page 1

Scroll to top